01.06.2013 | Erratum
Erratum to: Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor
Erschienen in: Clinical and Translational Oncology | Ausgabe 6/2013
Einloggen, um Zugang zu erhalten